Bruno Osuna

Audits rarely fail because of one big issue. They fail because of repeatable patterns. This short video breaks down what FDA inspectors see most often, including: ✅ CAPA documentation gaps ✅ Incomplete training records ✅ Traceability issues between design & production If your risk files or QMS processes touch any of these areas… it’s worth a 3-minute watch. #FDA #AuditReady #QualitySystems #ISO13485 #ISO14971 #CAPA #MedTech #RegulatoryAffairs #Qualira https://zurl.co/qRzlR

4

FDA expects complaint trending before CAPA initiation. From an inspection perspective, complaint trending is a diagnostic function, not an effectiveness check. If trending only occurs after CAPA opens, FDA assumes the escalation decision was not risk-informed and that the system reacted without understanding the signal. Why This Question Matters More Than Most Teams Realize If CAPA is your first tool, you already missed the signal. Read more: https://lnkd.in/dDNHNJdY #CAPA #FDACompliance #QualitySystems #ComplaintHandling #RiskBasedQuality #RegulatoryInspections #QualityManagement

1

One Consistent Lesson From FDA Warning Letters: Compliance failures are rarely isolated events they’re usually the result of weak systems, poor visibility, and delayed action. When CAPAs aren’t tracked effectively, data lacks integrity, or trends go unnoticed, small gaps turn into major observations. The lesson is clear: proactive, system driven compliance matters more than reactive fixes. Strengthen compliance before it’s tested. Read our full guide here : https://lnkd.in/gf8Fd7uc #FDAWarningLetters #RegulatoryAffairs #RegulatoryCompliance #QualitySystems #CAPA #AuditReadiness #DataIntegrity #PharmaQuality #LifeSciencesCompliance

2

1 Comment

18 months of FDA Warning Letters. Same 4 failures. Every time. → CAPA systems that don't catch root causes → SOPs nobody follows → Changes rolling out without validation → Data integrity gaps (FDA's new favorite) Your 2025 reality check: FDA already knows what they'll find at your next inspection. Do you? These aren't random citations. They're predictable patterns hitting companies still treating QMS as a checkbox exercise instead of operational advantage. Planning 2025? Fix these gaps now or explain them to FDA later. Let's talk before your inspection becomes a case study. #MedTech #FDA #QualityManagement

10

FDA QMSR inspections are shifting focus from intent to provable control. Leading manufacturers like Philips, Medtronic, and Johnson & Johnson MedTech are moving to real time traceability. RTLS enables automated eDHRs, audit trails, and full chain of custody across cleanrooms and labs. Teams report faster audits, fewer non conformances, and measurable ROI within months.This is not visibility for operations. This is infrastructure for compliance. Schedule a compliance review to assess QMSR readiness: https://lnkd.in/gb8Qfs7x #FDACompliance #QMSR #MedicalDeviceManufacturing #PharmaQuality #RTLS

13

5 Comments

In the final part of our Human Factors in CAPA series, we explore why traditional tactics for gaining leadership buy-in often miss the mark, and how creative, people-focused (and yes, unconventional) strategies can make all the difference. They don’t require a big budget, but they work—and they can change your entire quality culture. #CAPA #QualityAssurance #AssurX https://lnkd.in/e-irbTYm

2